nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP1A2—Dacarbazine—sarcoma	0.143	0.239	CbGbCtD
Gemfibrozil—CYP3A4—Thiotepa—sarcoma	0.136	0.226	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—sarcoma	0.0907	0.151	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—sarcoma	0.0702	0.117	CbGbCtD
Gemfibrozil—CYP3A4—Mitoxantrone—sarcoma	0.0583	0.0972	CbGbCtD
Gemfibrozil—CYP3A4—Vincristine—sarcoma	0.0401	0.0669	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—sarcoma	0.0368	0.0613	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—sarcoma	0.0251	0.0418	CbGbCtD
Gemfibrozil—PPARA—embryo—sarcoma	0.0016	0.0869	CbGeAlD
Gemfibrozil—SLCO1B1—mammary gland—sarcoma	0.00149	0.0812	CbGeAlD
Gemfibrozil—PPARA—hematopoietic system—sarcoma	0.00142	0.0776	CbGeAlD
Gemfibrozil—PPARA—connective tissue—sarcoma	0.00137	0.0747	CbGeAlD
Gemfibrozil—PPARA—smooth muscle tissue—sarcoma	0.00126	0.0683	CbGeAlD
Gemfibrozil—PPARA—skin of body—sarcoma	0.00124	0.0674	CbGeAlD
Gemfibrozil—Mediastinal disorder—Etoposide—sarcoma	0.00106	0.00277	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00106	0.00277	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00105	0.00275	CcSEcCtD
Gemfibrozil—Arthralgia—Mitoxantrone—sarcoma	0.00104	0.00273	CcSEcCtD
Gemfibrozil—Chest pain—Mitoxantrone—sarcoma	0.00104	0.00273	CcSEcCtD
Gemfibrozil—Myalgia—Mitoxantrone—sarcoma	0.00104	0.00273	CcSEcCtD
Gemfibrozil—Paraesthesia—Thiotepa—sarcoma	0.00104	0.00273	CcSEcCtD
Gemfibrozil—Alopecia—Etoposide—sarcoma	0.00103	0.00271	CcSEcCtD
Gemfibrozil—Somnolence—Thiotepa—sarcoma	0.00103	0.0027	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Vincristine—sarcoma	0.00103	0.00269	CcSEcCtD
Gemfibrozil—Oedema—Vincristine—sarcoma	0.00103	0.00269	CcSEcCtD
Gemfibrozil—Dyspepsia—Thiotepa—sarcoma	0.00102	0.00267	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00101	0.00265	CcSEcCtD
Gemfibrozil—Confusional state—Mitoxantrone—sarcoma	0.00101	0.00264	CcSEcCtD
Gemfibrozil—Nervous system disorder—Vincristine—sarcoma	0.00101	0.00264	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Epirubicin—sarcoma	0.00101	0.00264	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Vincristine—sarcoma	0.00101	0.00264	CcSEcCtD
Gemfibrozil—PPARA—lymphoid tissue—sarcoma	0.001	0.0546	CbGeAlD
Gemfibrozil—Anaphylactic shock—Mitoxantrone—sarcoma	0.001	0.00262	CcSEcCtD
Gemfibrozil—Oedema—Mitoxantrone—sarcoma	0.001	0.00262	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Thiotepa—sarcoma	0.001	0.00262	CcSEcCtD
Gemfibrozil—Photosensitivity—Doxorubicin—sarcoma	0.001	0.00262	CcSEcCtD
Gemfibrozil—Fatigue—Thiotepa—sarcoma	0.000998	0.00262	CcSEcCtD
Gemfibrozil—Dysgeusia—Etoposide—sarcoma	0.000998	0.00262	CcSEcCtD
Gemfibrozil—Fatigue—Dactinomycin—sarcoma	0.000991	0.0026	CcSEcCtD
Gemfibrozil—Pain—Thiotepa—sarcoma	0.00099	0.0026	CcSEcCtD
Gemfibrozil—Constipation—Thiotepa—sarcoma	0.00099	0.0026	CcSEcCtD
Gemfibrozil—Shock—Mitoxantrone—sarcoma	0.000984	0.00258	CcSEcCtD
Gemfibrozil—Pain—Dactinomycin—sarcoma	0.000983	0.00258	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Mitoxantrone—sarcoma	0.000979	0.00257	CcSEcCtD
Gemfibrozil—Eczema—Doxorubicin—sarcoma	0.000977	0.00256	CcSEcCtD
Gemfibrozil—Skin disorder—Mitoxantrone—sarcoma	0.000971	0.00255	CcSEcCtD
Gemfibrozil—Feeling abnormal—Thiotepa—sarcoma	0.000954	0.0025	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dactinomycin—sarcoma	0.000947	0.00248	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Thiotepa—sarcoma	0.000947	0.00248	CcSEcCtD
Gemfibrozil—Anaemia—Etoposide—sarcoma	0.000942	0.00247	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dactinomycin—sarcoma	0.00094	0.00246	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vincristine—sarcoma	0.000936	0.00245	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00093	0.00244	CcSEcCtD
Gemfibrozil—Paraesthesia—Vincristine—sarcoma	0.000922	0.00242	CcSEcCtD
Gemfibrozil—Urticaria—Thiotepa—sarcoma	0.00092	0.00241	CcSEcCtD
Gemfibrozil—Vertigo—Etoposide—sarcoma	0.000916	0.0024	CcSEcCtD
Gemfibrozil—Abdominal pain—Thiotepa—sarcoma	0.000915	0.0024	CcSEcCtD
Gemfibrozil—Leukopenia—Etoposide—sarcoma	0.000912	0.00239	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000911	0.00239	CcSEcCtD
Gemfibrozil—Abdominal pain—Dactinomycin—sarcoma	0.000909	0.00238	CcSEcCtD
Gemfibrozil—SLCO1B1—hematopoietic system—sarcoma	0.000908	0.0495	CbGeAlD
Gemfibrozil—Paraesthesia—Mitoxantrone—sarcoma	0.000898	0.00235	CcSEcCtD
Gemfibrozil—Loss of consciousness—Etoposide—sarcoma	0.000896	0.00235	CcSEcCtD
Gemfibrozil—Cough—Etoposide—sarcoma	0.000889	0.00233	CcSEcCtD
Gemfibrozil—Somnolence—Mitoxantrone—sarcoma	0.000889	0.00233	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vincristine—sarcoma	0.000887	0.00232	CcSEcCtD
Gemfibrozil—Fatigue—Vincristine—sarcoma	0.000885	0.00232	CcSEcCtD
Gemfibrozil—Convulsion—Etoposide—sarcoma	0.000883	0.00232	CcSEcCtD
Gemfibrozil—Dyspepsia—Mitoxantrone—sarcoma	0.00088	0.00231	CcSEcCtD
Gemfibrozil—Pain—Vincristine—sarcoma	0.000878	0.0023	CcSEcCtD
Gemfibrozil—Constipation—Vincristine—sarcoma	0.000878	0.0023	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—sarcoma	0.000876	0.0023	CcSEcCtD
Gemfibrozil—Chest pain—Etoposide—sarcoma	0.000868	0.00227	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—sarcoma	0.000866	0.00227	CcSEcCtD
Gemfibrozil—Fatigue—Mitoxantrone—sarcoma	0.000862	0.00226	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000862	0.00226	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—sarcoma	0.000857	0.00225	CcSEcCtD
Gemfibrozil—Pain—Mitoxantrone—sarcoma	0.000855	0.00224	CcSEcCtD
Gemfibrozil—Constipation—Mitoxantrone—sarcoma	0.000855	0.00224	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—sarcoma	0.000848	0.00222	CcSEcCtD
Gemfibrozil—CYP2C8—mammary gland—sarcoma	0.000848	0.0462	CbGeAlD
Gemfibrozil—Gastrointestinal pain—Vincristine—sarcoma	0.00084	0.0022	CcSEcCtD
Gemfibrozil—Confusional state—Etoposide—sarcoma	0.000839	0.0022	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—sarcoma	0.000837	0.00219	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Etoposide—sarcoma	0.000832	0.00218	CcSEcCtD
Gemfibrozil—Asthenia—Thiotepa—sarcoma	0.000831	0.00218	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—sarcoma	0.000825	0.00216	CcSEcCtD
Gemfibrozil—Feeling abnormal—Mitoxantrone—sarcoma	0.000824	0.00216	CcSEcCtD
Gemfibrozil—Pruritus—Thiotepa—sarcoma	0.000819	0.00215	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000818	0.00214	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Etoposide—sarcoma	0.000814	0.00214	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—sarcoma	0.000812	0.00213	CcSEcCtD
Gemfibrozil—Abdominal pain—Vincristine—sarcoma	0.000812	0.00213	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—sarcoma	0.00081	0.00212	CcSEcCtD
Gemfibrozil—Skin disorder—Etoposide—sarcoma	0.000808	0.00212	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—sarcoma	0.000804	0.00211	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—sarcoma	0.000802	0.0021	CcSEcCtD
Gemfibrozil—Urticaria—Mitoxantrone—sarcoma	0.000794	0.00208	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—sarcoma	0.000793	0.00208	CcSEcCtD
Gemfibrozil—Diarrhoea—Thiotepa—sarcoma	0.000792	0.00208	CcSEcCtD
Gemfibrozil—Abdominal pain—Mitoxantrone—sarcoma	0.000791	0.00207	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—sarcoma	0.000786	0.00206	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—sarcoma	0.000785	0.00206	CcSEcCtD
Gemfibrozil—PPARA—testis—sarcoma	0.000781	0.0425	CbGeAlD
Gemfibrozil—Pancytopenia—Epirubicin—sarcoma	0.000779	0.00204	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—sarcoma	0.000774	0.00203	CcSEcCtD
Gemfibrozil—Dizziness—Thiotepa—sarcoma	0.000766	0.00201	CcSEcCtD
Gemfibrozil—CYP2C9—mammary gland—sarcoma	0.000753	0.041	CbGeAlD
Gemfibrozil—Eosinophilia—Doxorubicin—sarcoma	0.000751	0.00197	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—sarcoma	0.000748	0.00196	CcSEcCtD
Gemfibrozil—Paraesthesia—Etoposide—sarcoma	0.000747	0.00196	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—sarcoma	0.000744	0.00195	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—sarcoma	0.000742	0.00194	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—sarcoma	0.000739	0.00194	CcSEcCtD
Gemfibrozil—PPARA—liver—sarcoma	0.000738	0.0402	CbGeAlD
Gemfibrozil—Asthenia—Vincristine—sarcoma	0.000737	0.00193	CcSEcCtD
Gemfibrozil—Vomiting—Thiotepa—sarcoma	0.000736	0.00193	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—sarcoma	0.000731	0.00192	CcSEcCtD
Gemfibrozil—Rash—Thiotepa—sarcoma	0.00073	0.00191	CcSEcCtD
Gemfibrozil—Dermatitis—Thiotepa—sarcoma	0.000729	0.00191	CcSEcCtD
Gemfibrozil—Headache—Thiotepa—sarcoma	0.000725	0.0019	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—sarcoma	0.000725	0.0019	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—sarcoma	0.000721	0.00189	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—sarcoma	0.000719	0.00188	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Etoposide—sarcoma	0.000718	0.00188	CcSEcCtD
Gemfibrozil—Asthenia—Mitoxantrone—sarcoma	0.000718	0.00188	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—sarcoma	0.000717	0.00188	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—sarcoma	0.000717	0.00188	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—sarcoma	0.000713	0.00187	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—sarcoma	0.000711	0.00186	CcSEcCtD
Gemfibrozil—Pain—Etoposide—sarcoma	0.000711	0.00186	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—sarcoma	0.000711	0.00186	CcSEcCtD
Gemfibrozil—Diarrhoea—Vincristine—sarcoma	0.000703	0.00184	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—sarcoma	0.000693	0.00182	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—sarcoma	0.000691	0.00181	CcSEcCtD
Gemfibrozil—Nausea—Thiotepa—sarcoma	0.000688	0.0018	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—sarcoma	0.000686	0.0018	CcSEcCtD
Gemfibrozil—Feeling abnormal—Etoposide—sarcoma	0.000685	0.0018	CcSEcCtD
Gemfibrozil—Diarrhoea—Mitoxantrone—sarcoma	0.000684	0.00179	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—sarcoma	0.000683	0.00179	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—sarcoma	0.00068	0.00178	CcSEcCtD
Gemfibrozil—Dizziness—Vincristine—sarcoma	0.000679	0.00178	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—sarcoma	0.000665	0.00174	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—sarcoma	0.000663	0.00174	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—sarcoma	0.000661	0.00173	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—sarcoma	0.000659	0.00173	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—sarcoma	0.000658	0.00172	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—sarcoma	0.000658	0.00172	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—sarcoma	0.000658	0.00172	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—sarcoma	0.000653	0.00171	CcSEcCtD
Gemfibrozil—Vomiting—Vincristine—sarcoma	0.000653	0.00171	CcSEcCtD
Gemfibrozil—Rash—Vincristine—sarcoma	0.000647	0.0017	CcSEcCtD
Gemfibrozil—Dermatitis—Vincristine—sarcoma	0.000647	0.0017	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—sarcoma	0.000645	0.00169	CcSEcCtD
Gemfibrozil—Headache—Vincristine—sarcoma	0.000643	0.00169	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—sarcoma	0.00064	0.00168	CcSEcCtD
Gemfibrozil—Vomiting—Mitoxantrone—sarcoma	0.000636	0.00167	CcSEcCtD
Gemfibrozil—Rash—Mitoxantrone—sarcoma	0.000631	0.00165	CcSEcCtD
Gemfibrozil—Dermatitis—Mitoxantrone—sarcoma	0.00063	0.00165	CcSEcCtD
Gemfibrozil—Headache—Mitoxantrone—sarcoma	0.000626	0.00164	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—sarcoma	0.000613	0.00161	CcSEcCtD
Gemfibrozil—Nausea—Vincristine—sarcoma	0.00061	0.0016	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—sarcoma	0.000609	0.0016	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—sarcoma	0.000604	0.00158	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—sarcoma	0.000597	0.00156	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—sarcoma	0.000597	0.00156	CcSEcCtD
Gemfibrozil—Nausea—Mitoxantrone—sarcoma	0.000594	0.00156	CcSEcCtD
Gemfibrozil—CYP2C19—hematopoietic system—sarcoma	0.000592	0.0322	CbGeAlD
Gemfibrozil—Mediastinal disorder—Epirubicin—sarcoma	0.000591	0.00155	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—sarcoma	0.000589	0.00154	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—sarcoma	0.00058	0.00152	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—sarcoma	0.000575	0.00151	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—sarcoma	0.000569	0.00149	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—sarcoma	0.000568	0.00149	CcSEcCtD
Gemfibrozil—PPARA—lymph node—sarcoma	0.000566	0.0308	CbGeAlD
Gemfibrozil—Flatulence—Epirubicin—sarcoma	0.000563	0.00148	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—sarcoma	0.000561	0.00147	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—sarcoma	0.000559	0.00147	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—sarcoma	0.000555	0.00145	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—sarcoma	0.00055	0.00144	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—sarcoma	0.000547	0.00143	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—sarcoma	0.000538	0.00141	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—sarcoma	0.000537	0.00141	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—sarcoma	0.000532	0.00139	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—sarcoma	0.000529	0.00139	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—sarcoma	0.000528	0.00138	CcSEcCtD
Gemfibrozil—Rash—Etoposide—sarcoma	0.000524	0.00138	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—sarcoma	0.000524	0.00137	CcSEcCtD
Gemfibrozil—Headache—Etoposide—sarcoma	0.000521	0.00137	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—sarcoma	0.000521	0.00137	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—sarcoma	0.000519	0.00136	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—sarcoma	0.000518	0.00136	CcSEcCtD
Gemfibrozil—CYP2C8—hematopoietic system—sarcoma	0.000517	0.0281	CbGeAlD
Gemfibrozil—Nervousness—Doxorubicin—sarcoma	0.000513	0.00135	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—sarcoma	0.000513	0.00135	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—sarcoma	0.000512	0.00134	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—sarcoma	0.000511	0.00134	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—sarcoma	0.000502	0.00132	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—sarcoma	0.000499	0.00131	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—sarcoma	0.000498	0.00131	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—sarcoma	0.000495	0.0013	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—sarcoma	0.000494	0.0013	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—sarcoma	0.000489	0.00128	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—sarcoma	0.000486	0.00128	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—sarcoma	0.000486	0.00128	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—sarcoma	0.000486	0.00128	CcSEcCtD
Gemfibrozil—CYP1A2—hematopoietic system—sarcoma	0.000483	0.0263	CbGeAlD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000483	0.00127	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—sarcoma	0.000475	0.00125	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—sarcoma	0.000474	0.00124	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—sarcoma	0.000473	0.00124	CcSEcCtD
Gemfibrozil—SLCO1B1—liver—sarcoma	0.000471	0.0256	CbGeAlD
Gemfibrozil—Confusional state—Epirubicin—sarcoma	0.00047	0.00123	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—sarcoma	0.000466	0.00122	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—sarcoma	0.000466	0.00122	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—sarcoma	0.000465	0.00122	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—sarcoma	0.000461	0.00121	CcSEcCtD
Gemfibrozil—CYP2C9—hematopoietic system—sarcoma	0.000459	0.025	CbGeAlD
Gemfibrozil—Shock—Epirubicin—sarcoma	0.000459	0.0012	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—sarcoma	0.000458	0.0012	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—sarcoma	0.000457	0.0012	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—sarcoma	0.000457	0.0012	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—sarcoma	0.000453	0.00119	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—sarcoma	0.00045	0.00118	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—sarcoma	0.00045	0.00118	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—sarcoma	0.00045	0.00118	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000447	0.00117	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—sarcoma	0.000435	0.00114	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—sarcoma	0.000431	0.00113	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—sarcoma	0.000431	0.00113	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000425	0.00111	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—sarcoma	0.000424	0.00111	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—sarcoma	0.000423	0.00111	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—sarcoma	0.000422	0.00111	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—sarcoma	0.000419	0.0011	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—sarcoma	0.000419	0.0011	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—sarcoma	0.000415	0.00109	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—sarcoma	0.00041	0.00108	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000403	0.00106	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—sarcoma	0.000402	0.00105	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—sarcoma	0.000399	0.00105	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—sarcoma	0.000399	0.00105	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000393	0.00103	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—sarcoma	0.000387	0.00102	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—sarcoma	0.000384	0.00101	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—sarcoma	0.000384	0.00101	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—sarcoma	0.000381	0.001	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—sarcoma	0.00038	0.000996	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000372	0.000977	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—sarcoma	0.000372	0.000975	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—sarcoma	0.00037	0.000971	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—sarcoma	0.000369	0.000967	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—sarcoma	0.000369	0.000967	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—sarcoma	0.000369	0.000966	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—sarcoma	0.000356	0.000932	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—sarcoma	0.000353	0.000925	CcSEcCtD
Gemfibrozil—CYP3A4—hematopoietic system—sarcoma	0.00035	0.019	CbGeAlD
Gemfibrozil—Urticaria—Doxorubicin—sarcoma	0.000343	0.000899	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—sarcoma	0.000341	0.000894	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—sarcoma	0.000335	0.000877	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—sarcoma	0.00033	0.000865	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—sarcoma	0.000319	0.000836	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—sarcoma	0.00031	0.000812	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—sarcoma	0.000308	0.000808	CcSEcCtD
Gemfibrozil—CYP2C19—liver—sarcoma	0.000307	0.0167	CbGeAlD
Gemfibrozil—Pruritus—Doxorubicin—sarcoma	0.000305	0.0008	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—sarcoma	0.000296	0.000777	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—sarcoma	0.000295	0.000774	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—sarcoma	0.000294	0.000771	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—sarcoma	0.000294	0.00077	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—sarcoma	0.000292	0.000766	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—sarcoma	0.000285	0.000748	CcSEcCtD
Gemfibrozil—CYP2C8—testis—sarcoma	0.000283	0.0154	CbGeAlD
Gemfibrozil—Nausea—Epirubicin—sarcoma	0.000277	0.000726	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—sarcoma	0.000274	0.000719	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—sarcoma	0.000272	0.000713	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—sarcoma	0.000272	0.000713	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—sarcoma	0.00027	0.000709	CcSEcCtD
Gemfibrozil—CYP2C8—liver—sarcoma	0.000268	0.0146	CbGeAlD
Gemfibrozil—Nausea—Doxorubicin—sarcoma	0.000256	0.000672	CcSEcCtD
Gemfibrozil—CYP1A2—liver—sarcoma	0.00025	0.0136	CbGeAlD
Gemfibrozil—CYP2C9—liver—sarcoma	0.000238	0.0129	CbGeAlD
Gemfibrozil—CYP3A4—liver—sarcoma	0.000181	0.00987	CbGeAlD
